From left to right: New Lumendi staff - James White; Eric Coolidge; Dennis Daniels and Ian Shaw
From left to right: New Lumendi staff - James White; Eric Coolidge; Dennis Daniels and Ian Shaw
From left to right: New Lumendi staff – James White; Eric Coolidge; Dennis Daniels and Ian Shaw

Previously we introduced to you Mike Parrilla – Chief Operating Officer as well as as William Wick our CFO

Today we introduce to you four more members of our Lumendi LLC team.

Eric Coolidge, VP Marketing

Eric Coolidge

Eric Coolidge is medical device marketing professional with over twenty years of experience in the areas of GI surgery, gastroenterology, thoracic surgery, gynecology and orthopedics.  Over his career he has led many diverse product marketing teams to develop, launch and manage the lifecycles of dozens of capital and consumable products, often achieving year-over-year double digit growth. Many products involved the development and launch of various new and novel technologies into the medical device market space including fluorescence imaging, narrow band imaging and natural orifice surgery devices.

Most recently he held the position of Group Director of Clinical Marketing at Novadaq Technologies.  Novadaq is the global leader in developing and pioneering the use of surgical fluorescence imaging to assess tissue perfusion and cancer staging.  Eric built and led a marketing team that launched the first ever minimally invasive fluorescence video platform for GI, Thoracic and GYN oncology surgery.  Over the past four years Novadaq’s revenue has grown from $16M to $65M with fluorescence imaging in minimally invasive surgery now recognized as a critical component of assessing tissue perfusion and enhancing cancer staging in numerous applications.

Prior to Novadaq, Eric spent twelve years with Olympus, Inc. managing marketing teams responsible for over $250M in revenue and launching two major video platforms that included significant advancements in medical and surgical imaging.  In addition, he was responsible for developing the GI market for intraluminal surgery which involved among other applications the resection of large and difficult polyps.

Eric began his medical device career in orthopedic sales with Johnson & Johnson/Depuy and Osteotech Inc and later moved into marketing while at Osteotech followed by a product management role in spinal fixation with US Surgical.

Dennis Daniels, Director of Regulatory Affairs & Quality Assurance

Dennis Daniels

Dennis Daniels is a medical device Quality Assurance and Regulatory Affairs management professional with experience in both medical equipment (ventilators, defibrillators, respiratory monitors/sensors, and hemodialysis) and also sterile /nonsterile consumable products.  He has over 25 years Q&R management experience working for companies such as Philips Healthcare, NeuroVista Inc., Heartstream, Inc., Aksys Ltd. and Baxter Healthcare.

He has experience establishing and maintaining Quality Management Systems, leading compliance inspections, leading remediation activities, interfacing with FDA and global regulatory agencies for product clearance and approval, leading supplier quality assurance activities and improving product reliability and performance.

Most recently Dennis was a Director of Quality Assurance and Regulatory Affairs at Philips Healthcare for their ventilation and respiratory monitoring businesses.  Dennis has a B.S. in Industrial Engineering from Bradley University and a Master’s Degree in Engineering Management from Northwestern University.

Ian Shaw, VP R&D
Ian Shaw

Ian is a Senior Engineering/Program Management and Research executive with over 35 years of progressive experience in successfully developing products and technologies for the Medical Device and other high technology industries. Most recently he held the position of Senior Director of Advanced Product Development for Hologic, Inc., Breast Health Division.

Hologic’s Breast Health Division is a leading developer of systems for the detection and intervention of breast cancer. Ian led the team that developed the first Breast Tomosynthesis system, which is acknowledged to being a major breakthrough in the early detection of breast cancer. Ian also led the group who developed and demonstrated the feasibility of new devices and technologies to maintain the product pipeline.

Prior to joining Hologic, Ian spent many years in executive and senior management with several companies, focusing on Program, Project and Functional management of technical teams.

James J. White, VP of Medical Affairs, Lumendi

James J. White

Dr. White has over 10 years of experience in the minimally invasive surgical device industry. Prior to joining Lumendi, Dr. White was serving as VP of Medical Affairs for USGI Medical during an 8 year tenure. USGI is a developer of devices for incisionless weight loss surgery.

Prior to USGI Medical, Dr. White held the position of Director of Clinical Affairs for Power Medical Interventions, a company focused on flexible, powered surgical staplers. His regulatory and clinical experience includes development and management of a 350+ patient, multi-center, randomized, pivotal trial. From 1995 to 2003, he was the sole owner and board certified family physician of a large medical practice.

Dr. White holds a D.O. degree from the Philadelphia College of Osteopathic Medicine and a BS in Natural Sciences from Muhlenberg College.

Join the discussion

  • Have your say, welcome our new staff
  • Have a question about strategy, regulation and so forth, pose it here
Professor Urs E. Gattiker - DrKPI is corporate Europe's leading social media metrics expert (see his books). He continues to work with start-ups. Urs is CEO of CyTRAP Labs GmbH.

2 Thoughts on “Lumendi LLC: Welcome to our new team members”

  • Congratulations! You have a remarkable platform a revolution approach for colon therapy.
    A special regards to my friend Jim who contributed for the success of POSE procedure
    Wish you a happy new year a lots a success
    Dr Tarek a Saleh
    Dubai. UAE

    • Dear Dr Saleh

      Thanks so much for your comment. I am not sure if our DiLumen technology could be called a “therapy tool”.
      How Jim contributed to the success of the Primary Obesity Surgery Endoluminal, or POSE procedure is not clear to me. POSE is, of course, also an an endoscopic incisionless weight loss procedure.
      With POSE we can reduce the size of the stomach.
      So maybe you can explain?

Leave a Reply

Your email address will not be published. Required fields are marked *